NWLC Reacts to FDA Approval of First Over-the-Counter Contraceptive Pill
Washington, DC – Today, the Food and Drug Administration approved Opill as the first-ever over-the-counter birth control pill in the United States. The decision reflects the extensive data and research presented to the FDA earlier this year showing that progestin-only birth control pills like Opill are safe and effective for over-the-counter use.
The following is a statement from Mara Gandal-Powers, Director of Birth Control Access and Senior Counsel for Reproductive Rights and Health at the National Women’s Law Center:
“The FDA’s approval of Opill for over-the-counter sale is a monumental moment for reproductive health and contraception. Over-the-counter contraception has incredible potential to break down barriers to care. We are grateful to the advocates who recognized and kept the focus on the enormous beneficial impact this will have, especially on those who have the greatest barriers to care. We are committed to ensuring that this remarkable advancement in contraceptive access is widely available and covered by insurance for all who need it.
